XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Recently Adopted and Issued Accounting Guidance Recently Adopted and Issued Accounting Guidance (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Accounting Changes and Error Corrections [Abstract] |
Summary of Adoption of New Accounting Pronouncements | Select condensed consolidated balance sheet line items, which reflect the adoption of ASC 606, are as follows (in thousands):
| December 31, 2017
| As Reported |  | Impact of Adoption |  | As Adjusted
Other current assets | $ | 4,241 |  |  | $ | 912 |  |  | $ | 5,153 |
Other assets | 689 |  |  | 202 |  |  | 891 |
Total Assets | $ | 343,340 |  |  | $ | 1,114 |  |  | $ | 344,454 |
Accrued expenses and other liabilities | $ | 6,144 |  |  | $ | 1,406 |  |  | $ | 7,550 |
Long-term pharma contract liability | — |  |  | 283 |  |  | 283 |
Deferred income tax liability, net | 6,307 |  |  | 381 |  |  | 6,688 |
Stockholders' Equity | 172,918 |  |  | (956 | ) |  | 171,962 |
Total Liabilities and Stockholders' Equity | $ | 343,340 |  |  | $ | 1,114 |  |  | $ | 344,454 |
Select unaudited condensed consolidated statement of operations line items, which reflect the adoption of ASC 606, are as follows (in thousands):
| For the Three Months Ended March 31, 2017
| As Reported |  | Impact of Adoption |  | As Adjusted
Net Revenue |  |  |  |  |
Clinical Testing | $ | 56,690 |  |  | $ | (3,783 | ) |  | $ | 52,907 |
Pharma Services | 4,986 |  |  | (465 | ) |  | 4,521 |
Total Revenue | $ | 61,676 |  |  | $ | (4,248 | ) |  | $ | 57,428 |
Gross Profit | $ | 27,196 |  |  | $ | (4,248 | ) |  | $ | 22,948 |
Total operating expenses | $ | 27,311 |  |  | $ | (3,783 | ) |  | $ | 23,528 |
Loss from Operations | (115 | ) |  | (465 | ) |  | (580 | )
Interest expense | 1,364 |  |  | — |  |  | 1,364 |
Income tax (benefit) expense | (825 | ) |  | 46 |  |  | (779 | )
Net Loss | $ | (654 | ) |  | $ | (511 | ) |  | (1,165 | )

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.10-01.(b)(6)) -URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305 + Details
Name: | us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration